Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia

Background: Febrile neutropenia (FN) remains one of the most challenging problems in medical oncology and is a very severe side effect of chemotherapy. Its late consequences, when it is recurrent or of a severe grade, are dose reduction and therapy delays. Current guidelines allow the administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Căinap, Călin, Cetean-Gheorghe, Sânziana, Pop, Laura Ancuta, Leucuta, Daniel Corneliu, Piciu, Doina, Mester, Andra, Vlad, Cătălin, Ovidiu, Crişan, Gherman, Alexandra, Crişan, Cristina, Bereanu, Alina, Bălăcescu, Ovidiu, Constantin, Anne Marie, Dicu, Irina, Bălăcescu, Loredana, Stan, Adina, Achimaş-Cadariu, Patriciu, Căinap, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305666/
https://www.ncbi.nlm.nih.gov/pubmed/34208815
http://dx.doi.org/10.3390/medicina57070675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305666/
https://www.ncbi.nlm.nih.gov/pubmed/34208815
http://dx.doi.org/10.3390/medicina57070675

Ejemplares similares